|
Volumn 16, Issue SUPPL. 6, 2001, Pages 55-57
|
Lupus nephritis
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AZATHIOPRINE;
CHLORAMBUCIL;
COMPLEMENT COMPONENT C3;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
GONADORELIN AGONIST;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TESTOSTERONE;
ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RESPONSE;
HERPES ZOSTER;
HIGH RISK PATIENT;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
INFERTILITY;
KIDNEY BIOPSY;
KIDNEY FAILURE;
LUPUS ERYTHEMATOSUS NEPHRITIS;
OSTEOPOROSIS;
OVARY INSUFFICIENCY;
PRIORITY JOURNAL;
RISK FACTOR;
STEM CELL TRANSPLANTATION;
STEROID THERAPY;
URINE SEDIMENT;
|
EID: 0034786344
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/16.suppl_6.55 Document Type: Article |
Times cited : (4)
|
References (13)
|